Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Vivos Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −1 vs. Q4 2021
- Shares held
- 2.49M
- +251.8K (+11.3%) vs. Q4 2021
- Total value
- $6.66M
- +$1.63M (+32.5%) vs. Q4 2021
- New holders
- 6
- 11 more added
- Sold out
- 7
- 6 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VVOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $242.7K |
| Q1 2026 | 25 | $2.15M |
| Q4 2025 | 20 | $1.34M |
| Q3 2025 | 23 | $2.13M |
| Q2 2025 | 19 | $1.27M |
| Q1 2025 | 21 | $1.00M |
| Q4 2024 | 20 | $2.00M |
| Q3 2024 | 23 | $630.7K |
| Q2 2024 | 19 | $433.8K |
| Q1 2024 | 16 | $646.8K |
| Q4 2023 | 18 | $3.12M |
| Q3 2023 | 28 | $860.6K |
| Q2 2023 | 31 | $2.39M |
| Q1 2023 | 30 | $1.71M |
| Q4 2022 | 27 | $629.7K |
| Q3 2022 | 30 | $1.38M |
| Q2 2022 | 28 | $2.82M |
| Q1 2022 | 28 | $6.66M |
| Q4 2021 | 29 | $5.02M |
| Q3 2021 | 37 | $9.14M |
| Q2 2021 | 29 | $11.7M |
| Q1 2021 | 18 | $5.45M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Vivos Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 695,051 | $1.86M | 0.00% | +31,798+4.8% | Added |
| Russell Investments Group, Ltd. | 424,801 | $1.14M | 0.00% | +119,705+39.2% | Added |
| Bard Associates Inc | 212,704 | $570.0K | 0.20% | −798−0.4% | Reduced |
| Geode Capital Management, LLC | 201,748 | $540.0K | 0.00% | +90,285+81.0% | Added |
| Point72 Asset Management, L.P. | 170,264 | $456.0K | 0.00% | +170,264 | New |
| Perkins Capital Management Inc | 150,050 | $402.0K | 0.33% | +14,000+10.3% | Added |
| Boston Partners | 137,354 | $368.0K | 0.00% | +29,339+27.2% | Added |
| National Asset Management, Inc. | 98,574 | $265.0K | 0.01% | +19,304+24.4% | Added |
| Griffin Asset Management, Inc. | 70,200 | $188.0K | 0.02% | +27,200+63.3% | Added |
| Group One Trading, L.P. | 67,138 | $180.0K | 0.00% | +62,575+1,371.4% | Added |
| Credit Agricole S A | 59,103 | $158.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 48,135 | $129.0K | 0.00% | −2,313−4.6% | Reduced |
| State Street Corp | 45,650 | $122.0K | 0.00% | +27,417+150.4% | Added |
| Northern Trust Corp | 40,766 | $109.0K | 0.00% | +162+0.4% | Added |
| Susquehanna International Group, LLP | 23,740 | $64.0K | 0.00% | −42,579−64.2% | Reduced |
| Millennium Management LLC | 11,244 | $30.0K | 0.00% | +11,244 | New |
| Renaissance Technologies LLC | 10,900 | $29.0K | 0.00% | +10,900 | New |
| Tower Research Capital LLC (TRC) | 3,806 | $10.0K | 0.00% | −1,637−30.1% | Reduced |
| Rockefeller Capital Management L.P. | 3,500 | $9.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,621 | $9.00K | 0.00% | +1,220+50.8% | Added |
| Simplex Trading, LLC | 3,645 | $9.00K | 0.00% | +3,645 | New |
| Stephens Consulting, LLC | 1,500 | $4.02K | 0.00% | −1,500−50.0% | Reduced |
| Kozak & Associates, Inc. | 1,205 | $4.00K | 0.00% | 00.0% | Unchanged |
| Toth Financial Advisory Corp | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 150 | $1.00K | 0.00% | +150 | New |
| Global Retirement Partners, LLC | 570 | $1.00K | 0.00% | +570 | New |
| Wells Fargo & Company | 111 | $0 | 0.00% | −1,998−94.7% | Reduced |
| Royal Bank of Canada | 141 | $0 | 0.00% | 00.0% | Unchanged |
| Anson Funds Management LP | 0 | $0 | 0.00% | −122,297−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −117,215−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −26,063−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −19,200−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −17,083−100.0% | Sold out |
| Avalon Investment & Advisory | 0 | $0 | 0.00% | −15,269−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −26−100.0% | Sold out |